95 related articles for article (PubMed ID: 23712426)
1. The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis.
Mark R; Bermejo JL; Bierhaus A; Plinkert PK; Angel P; Hess J
Histol Histopathol; 2013 Dec; 28(12):1585-94. PubMed ID: 23712426
[TBL] [Abstract][Full Text] [Related]
2. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
[TBL] [Abstract][Full Text] [Related]
3. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
[TBL] [Abstract][Full Text] [Related]
4. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat.
Taccioli C; Wan SG; Liu CG; Alder H; Volinia S; Farber JL; Croce CM; Fong LY
Gastroenterology; 2009 Mar; 136(3):953-66. PubMed ID: 19111725
[TBL] [Abstract][Full Text] [Related]
5. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
6. Central role of RAGE-dependent neointimal expansion in arterial restenosis.
Sakaguchi T; Yan SF; Yan SD; Belov D; Rong LL; Sousa M; Andrassy M; Marso SP; Duda S; Arnold B; Liliensiek B; Nawroth PP; Stern DM; Schmidt AM; Naka Y
J Clin Invest; 2003 Apr; 111(7):959-72. PubMed ID: 12671045
[TBL] [Abstract][Full Text] [Related]
7. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
8. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
[TBL] [Abstract][Full Text] [Related]
9. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
Fong LY; Zhang L; Jiang Y; Farber JL
J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology.
Tang XH; Urvalek AM; Osei-Sarfo K; Zhang T; Scognamiglio T; Gudas LJ
Oncotarget; 2015 Sep; 6(27):24424-35. PubMed ID: 26110572
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
12. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer.
Jing RR; Cui M; Sun BL; Yu J; Wang HM
Genet Test Mol Biomarkers; 2010 Jun; 14(3):355-61. PubMed ID: 20578941
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
[TBL] [Abstract][Full Text] [Related]
15. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
16. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
17. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.
Landesberg R; Woo V; Huang L; Cozin M; Lu Y; Bailey C; Qu W; Pulse C; Schmidt AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):617-24. PubMed ID: 18206396
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo.
Leibold JS; Riehl A; Hettinger J; Durben M; Hess J; Angel P
J Invest Dermatol; 2013 Oct; 133(10):2400-2406. PubMed ID: 23594597
[TBL] [Abstract][Full Text] [Related]
19. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
20. Cellular signalling of the receptor for advanced glycation end products (RAGE).
Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
